glp-1 weight loss drug news today october 2025 Rhode Island considers ending Medicaid coverage of drugs for • Rhode Island Current How to Invest in GLP-1
Description
Neuroprotective Effects of GLP-1 Receptor Agonists in Neurodegenerative Disorders: A Large-Scale Propensity-Matched Cohort Study
The pharmaceutical industry, represented by the trade organization PhRMA, would like to see Medicare rules changed to allow more patients to take the drugs and is pushing for more oversight and reining in of some of the compounding pharmacies that sell GLP-1 drugs directly to consumers
77 th American Diabetes Association 2017 Scientific Sessions
PMID: 33714600
